KOE:214450

PharmaResearch Co., Ltd. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:48 UTC

Last close

n/aKRW

Market data

14.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
22.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
30.8%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
28.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.31Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.5%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

1,166

2016-12-31 to 2025-12-31100 at the start1,166

Sales: 100.00 on 2016-12-31 to 1165.80 on 2025-12-31, up 1066%.

Profit

1,187

2016-12-31 to 2025-12-31100 at the start1,187

Profit: 100.00 on 2016-12-31 to 1187.15 on 2025-12-31, up 1087%.

Shares in issue

110

2016-12-31 to 2025-12-31100 at the start110

Shares in issue: 100.00 on 2016-12-31 to 109.82 on 2025-12-31, up 10%.

Sales is at 1166, Profit is at 1187, Shares in issue is at 110, against 100 in 2016.

Sales is at 1166, Profit is at 1187, Shares in issue is at 110, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 1001,166
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Profit, where the first year is 1001,187
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Shares in issue, where the first year is 100110
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW